Jazz Pharmaceuticals PLC (JAZZ)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 4,093,760 | 3,737,000 | 3,085,730 | 3,965,190 | 3,659,740 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $4,093,760K
= 0.00
The debt-to-equity ratio of Jazz Pharmaceuticals PLC has been consistently at 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not utilized any debt financing during this period to support its operations or growth. A debt-to-equity ratio of 0.00 signifies that the company's total liabilities are equal to zero or significantly lower than its total equity. While having low or zero debt can be viewed positively as it indicates a lower financial risk and less dependence on external financing, it is important to consider the overall financial health and future funding needs of the company in the long term. The consistent zero debt-to-equity ratio may imply that Jazz Pharmaceuticals PLC has been managing its capital structure prudently without relying on debt to fund its operations or expansion.
Peer comparison
Dec 31, 2024